[Myocardial cellular mechanism of action of calcium antagonists].
D008841:Actin Cytoskeleton / Q000187:drug effects; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology* / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy / Q000378:metabolism; D004110:Diltiazem / Q000494:pharmacology; D006321:Heart / Q000187:drug effects*; D006801:Humans; D008929:Mitochondria, Heart / Q000187:drug effects; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism / Q000648:ultrastructure; D009543:Nifedipine / Q000494:pharmacology; D012508:Sarcolemma / Q000187:drug effects; D012519:Sarcoplasmic Reticulum / Q000187:drug effects; D014700:Verapamil / Q000494:pharmacology
D002121:Calcium Channel Blockers; D014700:Verapamil; D004110:Diltiazem; D009543:Nifedipine; D002118:Calcium
Meccanismo di azione cellulare miocardico dei "calcio-antagonisti".